Nucleic Acids Research, 2003, Vol. 31, No. 11 2735-2744
© 2003 Oxford University Press
Transcriptional regulation of the human MIP-1
promoter by RUNX1 and MOZ
School of Biological Sciences, University of Manchester, 2.205, Stopford Building, Oxford Road, Manchester, M13 9PT, UK
*To whom correspondence should be addressed. Tel: +44 161 275 5978; Fax: +44 161 275 5082; Email: paul.shore{at}man.ac.uk
The transcription factor RUNX1 (AML-1, PEBP2
B and CBFA2) is essential for definitive haematopoiesis, and chromosomal translocations involving the RUNX1 gene are frequently found in acute leukaemias. The gene encoding the histone acetyltransferase MOZ is also rearranged in some acute leukaemias, resulting in the expression of MOZ fusion proteins. MOZ has recently been shown to interact directly with RUNX1, indicating that MOZ fusion proteins act by deregulating RUNX1 function. Macrophage inflammatory protein-1 (MIP-1) is a proinflammatory cytokine that also inhibits proliferation of haematopoietic stem cells. Amongst the conserved sequence elements in the human MIP-1 promoter are two consensus RUNX sites. We have investigated the role of these RUNX sites in the regulation of the MIP-1 promoter by PMA/PHA stimulation in Jurkat T-cells. RUNX1 can specifically bind to both RUNX sites in vitro and chromatin immunoprecipitation assays demonstrated that endogenous RUNX1 is constitutively bound to the endogenous MIP-1 promoter. Mutation of the RUNX sites demonstrated that the proximal RUNX site is essential for PMA/PHA-stimulated activation of the MIP-1 promoter. Activation of the promoter can also be inhibited by heterologous expression of the repressor protein AML-1/ETO. We further demonstrate that MOZ can activate the MIP-1 promoter and that this activation is largely dependent upon the proximal RUNX site. Moreover, we show that co-expression of MOZ and RUNX1 can synergistically activate the MIP-1 promoter. The regulation of MIP-1 expression by RUNX1/MOZ is discussed in the context of MIP-1’s role as an inhibitor of haematopoietic stem cell proliferation and its potential importance in leukaemias associated with RUNX1 or MOZ chromosomal rearrangements.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. M. Perez-Campo, J. Borrow, V. Kouskoff, and G. Lacaud The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors Blood, May 14, 2009; 113(20): 4866 - 4874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rokudai, Y. Aikawa, Y. Tagata, N. Tsuchida, Y. Taya, and I. Kitabayashi Monocytic Leukemia Zinc Finger (MOZ) Interacts with p53 to Induce p21 Expression and Cell-cycle Arrest J. Biol. Chem., January 2, 2009; 284(1): 237 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ullah, N. Pelletier, L. Xiao, S. P. Zhao, K. Wang, C. Degerny, S. Tahmasebi, C. Cayrou, Y. Doyon, S.-L. Goh, et al. Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes Mol. Cell. Biol., November 15, 2008; 28(22): 6828 - 6843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Santourlidis, N. Graffmann, J. Christ, and M. Uhrberg Lineage-Specific Transition of Histone Signatures in the Killer Cell Ig-Like Receptor Locus from Hematopoietic Progenitor to NK Cells J. Immunol., January 1, 2008; 180(1): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Shiau, S.-Y. Chen, M.-Y. Chang, C.-H. Su, S.-Y. Chung, Y.-T. Yo, C.-R. Wang, and C.-L. Wu Prothymosin {alpha} Lacking the Nuclear Localization Signal as an Effective Gene Therapeutic Strategy in Collagen-Induced Arthritis J. Immunol., April 1, 2007; 178(7): 4688 - 4694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Collins, K. B. Kindle, S. Matsuda, C. Ryan, P. J. F. Troke, E. Kalkhoven, and D. M. Heery MOZ-TIF2 Alters Cofactor Recruitment and Histone Modification at the RARbeta2 Promoter: DIFFERENTIAL EFFECTS OF MOZ FUSION PROTEINS ON CBP- AND MOZ-DEPENDENT ACTIVATORS J. Biol. Chem., June 23, 2006; 281(25): 17124 - 17133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Katsumoto, Y. Aikawa, A. Iwama, S. Ueda, H. Ichikawa, T. Ochiya, and I. Kitabayashi MOZ is essential for maintenance of hematopoietic stem cells. Genes & Dev., May 15, 2006; 20(10): 1321 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Liang, Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk The Interleukin-1beta Gene Is Transcribed from a Poised Promoter Architecture in Monocytes J. Biol. Chem., April 7, 2006; 281(14): 9227 - 9237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Peterson, A. Boyapati, V. Ranganathan, A. Iwama, D. G. Tenen, S. Tsai, and D.-E. Zhang The Hematopoietic Transcription Factor AML1 (RUNX1) Is Negatively Regulated by the Cell Cycle Protein Cyclin D3 Mol. Cell. Biol., December 1, 2005; 25(23): 10205 - 10219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Inman, N. Li, and P. Shore Oct-1 Counteracts Autoinhibition of Runx2 DNA Binding To Form a Novel Runx2/Oct-1 Complex on the Promoter of the Mammary Gland-Specific Gene {beta}-casein Mol. Cell. Biol., April 15, 2005; 25(8): 3182 - 3193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Howcroft, J. D. Weissman, A. Gegonne, and D. S. Singer A T Lymphocyte-Specific Transcription Complex Containing RUNX1 Activates MHC Class I Expression J. Immunol., February 15, 2005; 174(4): 2106 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-J. Yang The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases Nucleic Acids Res., February 11, 2004; 32(3): 959 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Inman and P. Shore The Osteoblast Transcription Factor Runx2 Is Expressed in Mammary Epithelial Cells and Mediates osteopontin Expression J. Biol. Chem., December 5, 2003; 278(49): 48684 - 48689. [Abstract] [Full Text] [PDF]
|
|